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Hypochlorous acidInﬂammation plays a crucial role in neurodegenerative diseases, but the irritants responsible for this response
remain largely unknown. This report addressed the hypothesis that hypochlorous acid reacts with dopamine
to produce melanic precipitates that promote cerebral inﬂammation. Spectrophotometric studies demonstrated
that nM amounts of HOCl and dopamine react within seconds. A second-order rate constant for the reaction of
HOCl and dopamine of 2.5 × 104 M−1 s−1 was obtained by measuring loss of dopaminergic ﬂuorescence due
to HOCl. Gravimetric measurements, electron microscopy, elemental analysis, and a novel use of ﬂow cytometry
conﬁrmed that themajor product of this reaction is a precipitatewith an average diameter of 1.5 μm. Flow cytom-
etry was also used to demonstrate the preferential reaction of HOCl with dopamine rather than albumin. Engulf-
ment of the chlorodopamine particulates by phagocytes in vitro caused these cells to release TNFα and die.
Intrastriatal administration of 106 particles also increased the content of TNFα in the brain and led to a 50%
loss of the dopaminergic neurons in the nigra. These studies indicate that HOCl and dopamine react quickly
and preferentially with each other to produce particles that promote inﬂammation and neuronal death in the
brain.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The impetus for the studies described herein was the observation
of 3-chlorotyrosine in the brains of Alzheimer Disease (AD) patients [1].
3-Chlorotyrosine is uniquely formed by the reaction of hypochlorous
acid (HOCl) with tyrosyl residues [2,3]. HOCl is powerful two-electron
oxidant producedbymyeloperoxidasewhile reducinghydrogenperoxide
to water:
H2O2 þ Cl− þ Hþ→H2Oþ HOCl ð1Þ
Thus, 3-chlorotyrosine serves as a biomarker of the production of
HOCl and indicates that the myeloperoxidase expressed in AD brains
is active [1]. Since dopamine is derived metabolically from tyrosine, it
is plausible that this catecholamine might be chlorinated by HOCl
under the same conditions that give rise to 3-chlorotyrosine in the; AD, Alzheimer disease; IF,
dial terminal;PD,Parkinsondis-
rα
ry and Molecular Biology, New
82.
er).diseased brain, thereby providing a mechanism for the oxidative loss
of dopamine. While losses of dopamine do occur in AD [4], the loss of
this catecholamine is a deﬁning characteristic of Parkinson Disease
(PD). Myeloperoxidase is also active in PD [5]. These observations
suggested the hypothesis that the loss of dopamine in PD may be due,
in part, to chlorination by HOCl.
In the course of testing the above hypothesis, we observed that mix-
tures of HOCl and dopamine rapidly formed precipitates. This was to be
expected as neutral and basic solutions of catecholamines are known to
auto-oxidize and form precipitates [6]. The oxidation and precipitation
of dopamine is also thought to resemble the formation of neuromelanin
in the substantia nigra [7–10]. Zecca and his colleagues demonstrated
that injection of neuromelanin into the substantia nigra ofmice resulted
in signiﬁcant inﬂammation and loss of nigral neurons [11–13]. The
importance of these studies was the identiﬁcation of a possible irritant,
namely neuromelanin, for the initiation and promulgation of inﬂamma-
tion in PD. Neuromelanin is a dark pigment that occupies somuch of the
cytoplasm of nigral cells that it accounts for the dark coloration of this
nucleus [14]. The cells that bear neuromelanin are also those most
vulnerable to loss in PD [15,16]. Thus – on the basis of amount and
cell origin – neuromelanin released from dying neurons is likely to
act as an irritant of inﬂammatory cells in PD [11,12]. Based on these
observations, we hypothesized that the precipitates resulting from the
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of damaging neurons and promoting inﬂammation. The possibility that
PD involves the generation of tainted neuromelanins had been postulated
earlier by Halliday and her colleagues [17]. In this report, we examined
the propensity of HOCl and dopamine to react and precipitate, as well
as the inﬂammatory and toxic nature of the resulting precipitates.Fig. 2. HOCl quenches the ﬂuorescence of dopamine. Shown are representative traces
of the quenching of 50 μM dopamine by 25, 50, and 75 μM HOCl. The ﬂuorescence of
dopamine under the conditions of the experiments was ~18,000 ﬂuorescence units,
whichwas normalized to 100% and used to calculate the percentage changes due to HOCl.2. Results
2.1. Physiological amounts of HOCl and dopamine react within seconds
Dopamine concentrations in the cytosol or synapses of nigral neu-
rons range from10−5 to 10−8M [18–21]. The amount of HOCl produced
in the diseased brain, however, is not known but local amounts of
10−8 M are a reasonable estimate given that 106 neutrophils – the
main source of HOCl in the body - generate 10−5 M amounts [22].
Given these considerations, we sought to determine the likelihood of
HOCl and dopamine reacting at physiologically-relevant concentrations
by spectrophotometric methods.
The UV-visible spectrum of 50 nM dopamine exhibits prominent
absorbance from 210 to 240 nm and 255 to295 nm attributed to the
amine and catechol moieties respectively (Fig. 1) [23] HOCl increased
these absorbances with no demonstrable isobestic points. Addition of ei-
ther 25 or 50 nM HOCl increased the absorbance from 210 to 320 nm
within the period taken to record the ﬁrst spectrum: 5 to 45 s (Fig. 1A).
The magnitude of this change remained the same for the ensuing
10 min (not shown) indicating that the reaction of HOCl was essentially
complete within seconds. This was not the case for the reaction with
100nMHOCl and 50nMdopaminewhich continued to increase in absor-
bance over 10min (Fig. 1B). For example, 100 nMHOCl produced 4.0, 8.9
and 9.8-fold increases in absorbance at 309 nm with 10 min (Fig. 1B).
These results indicate that nM amounts of HOCl and dopamine react
with each other to a signiﬁcant extent within seconds.
To estimate the rate of at least one of the reactions between HOCl
and dopamine we took advantage of the inherent ﬂuorescence of
dopamine [24] and the fact that chlorination of the catechol ring
quenches aromatic ﬂuorescence (Fig. 2). This ﬁgure shows thatFig. 1.HOCl alters theUV-visible spectrumof dopamine. The spectrumof 50nMdopamine in PB
concentrations of 25, 50 and 100 nM) at 22 °C (A). Spectra obtained 5, 300 and 600 s after the add
represents the mean of at least four spectra that did not vary by more than 5% of the mean abs50 μM HOCl completely quenched the ﬂuorescence of an equimolar
amount of dopamine within seconds. The loss of dopamine ﬂuores-
cence due to HOCl proceeded with decaying exponential kinetics
indicative of a ﬁrst-order reaction between these molecules. The
rates of quenching were also linearly related to the tested HOCl
concentrations: 25 (Fig. 2A), 37.5, 50 and 75 μM (not shown) and
allowed a determination of the second-order rate constant for this
reaction of 2.5 × 104 M−1 s−1.2.2. HOCl chlorinates the catechol and amine groups of dopamine
Particles formed in mixtures of dopamine and HOCl clogged a
number of chromatographic matrices that were employed in attempts
to analyze the products of this reaction. The potential for clogging wasS is presented alongwith spectra obtained 5 sec following the addition ofHOCl (to theﬁnal
ition of 100 nMHOCl to 50nMdopamine, in PBS and at 22 °C, are also shown (B). Each line
orbance at all wavelengths.
939T.M. Jeitner et al. / Biochimica et Biophysica Acta 1852 (2015) 937–950ampliﬁed by the addition of organic solvents to aqueous preparations of
chlorodopamine which accelerate precipitation from these mixtures.
Chlorodopamine particles can be solubilized in NaOH, but the resulting
solutions form a clear gel when the pH is raised. Given these difﬁculties,
we sought to retard the aggregation of chlorodopamine. Aggregate for-
mation was retarded by acidic conditions and performing the reactions
in acidiﬁed methanol was found to be the more efﬁcient method of
slowing the precipitation of chlorodopamine. The products of dopamine
reacting with HOCl in acidiﬁed methanol were similar to those formed
in aqueous solution, as indicated by diode UV-spectrometry and thin
layer chromatography. This allowed a 1H-NMR study of reaction of
dopamine and HOCl in acidiﬁed deuterated methanol (Fig. 3).
The 1H-NMR spectrum of dopamine is shown in Fig. 3 (top). The
chemical shift assignments are based on literature values [25,26]. The
lower-ﬁeld portion of the spectrum (right) contains 2 triplets corre-
sponding to the two methylene groups on the ethylamine portion of
the molecule. The high ﬁeld region (left) shows the aromatic protons.
The addition of equimolar amounts of HOCl to dopamine in deuterated
water resulted in the immediate formation of a dark precipitate, howev-
er no change was observed in the NMR spectrum. When HOCl was
added to dopamine in acidiﬁedmethanol, immediate precipitate forma-
tion was also observed, but the slowing of the reaction allowed the for-
mation and chlorinated intermediates, which were identiﬁed from the
NMR spectrum in Fig. 3 (bottom). In the aliphatic region, two additional
triplets could be seen (2′-NH-Cl at 2.96 ppm and 2′-N-Cl2 3.02 ppm at
which represent mono-chlorination (~10%) and di-chlorination (~1%)
of the amine group. The formation ofmultiple species results in a broad-
ening of the triplet in position 1. In the aromatic region, we see NMR
spectra consistent with chlorination at the 5 position. The intensity of
the signal from proton 5 is reduced, and two new peaks are formed,
labeled 3* and 6*, appearing as singlets as the coupling to the 5 position
is lost. Thus, the major compound formed by the addition of HOCl to
dopamine in presence of acidiﬁed deuterated methanol was 5-chloro-4-
(2-aminoethyl)benzene-1,2-diol. Signiﬁcant amounts of N,5-dichloro-4-Fig. 3. 1H-NMR spectra of dopamine and themoieties chlorinated byHOCl. The upper tracings sh
lower tracings show the changes due to the addition of HOCl.(2-aminoethyl)benzene-1,2-diol and N-chloro-4-(2-aminoethyl)
benzene-1,2-diol were also formed under these conditions.
2.3. Themajor products of the reaction of HOCl and dopamine is a chlorine-
containing precipitate
Neutral and alkaline solutions of dopamine auto-oxidize and form
precipitates [6]. The addition of HOCl to dopamine, at ﬁnal concentra-
tions of 20 and 10mM respectively, also resulted in measurable precip-
itation (Fig. 4). Moreover, precipitation was favored by neutral and not
acidic pH conditions (Fig. 4A, p b 0.01).Melanic precipitates also formed
in solutions of dopamine in PBS, but at a much slower rate than solution
containing dopamine andHOCl in PBS (not shown). Precipitates formed
within min of the addition of HOCl to dopamine and attained a mass
greater than that of the initial amount of dopamine within 24 h
(Fig. 4B). This increase in mass is most likely due to the incorporation
of chlorine into the reaction products as indicated by elemental analysis
(Table 1). These data indicate that the major product of HOCl and
dopamine is precipitate containing C:H:O:N:Cl with an approximate
molecular ratio of 22: 20:10:3:1 (Table 1).
2.4. HOCl and dopamine react to form 1.5 μm diameter aggregates
The particulate material produced by the reaction of dopamine and
HOCl was composed of aggregated particles (Fig. 5A). Each particle
had an approximate diameter of 100 nm. The arrangement of particles
within the aggregates suggested that the process of aggregation
proceeded by the successive addition of particles as depicted in
Fig. 4B. Support for this idea was provided by ﬂow cytometric analysis
of the aggregates, which demonstrated the existence of a range of
aggregate subpopulations (Fig. 5C). The smallestmeasurable aggregates
form a distinct subpopulation corresponding to an approximate diame-
ter of 50 nm and the ﬁrst or leftmost peak in Fig. 5C. The next 10
subpopulations appear as discrete peaks representing the successiveow themajor resonances due to the aromatic and aliphatic regions of dopamine,while the
Fig. 4. Themajor product of the reaction of HOCl and dopamine is a precipitate. Shown
are the amounts of precipitates resulting from the mixing of HOCl and dopamine at
ﬁnal concentrations of 10 mM and 20 mM respectively. The reaction was carried in
PBS at 22 °C for the indicated periods. Panel A depicts the later event in the reaction
while panel B depicts both the earliest time points in the reaction and the effect of
acidifying the reactionmixture. The amounts of precipitates are expressed relative to initial
dopamine mass. Precipitate masses were determined gravimetrically from ﬁve mL aliquots
of the dopamine/HOCl mixture ﬁltered through glass ﬁber (≤32 min) or paper discs
(N32 min). Data are expressed as mean ± SEM from four to six independent experiments.
Note: the abscissa and ordinate scales vary between the panels in this ﬁgure.
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increase in size the peaks begin to crowd and form a dominant peak at
433 Forward Scatter units corresponding to a size of 1.5 μm (Fig. 5C).2.5. HOCl reacts with dopamine to produce aggregates in the presence of
immobilized protein
The studies depicted in Fig. 5 were performed using dopamine and
HOCl at 10−2 M concentrations. Having demonstrated the possibility
of measuring aggregate formation by ﬂow cytometry, we then soughtTable 1
Elemental Analysis of chlorodopamine precipitates.
Elemental mass values are depicted as the mean ± SEM of three independent observa-
tions. Molecular proportions were obtained by dividing the mass values by the molecular
weights of the atoms. These values were then normalized relative to the amount of
chloride.
C H O N Cl
Mass (%) 51.0 ± 0.69 3.84 ± 0.10 30.7 ± 0.37 7.57 ± 0.08 6.89 ± 0.31
Molecular
proportions
21.9 19.7 9.91 2.79 1.00to determine the likelihood this formation at physiologically-relevant
or 0.2 mM concentrations of dopamine (Fig. 6A). A similar distribution
was obtained at 2 h (not shown)whereas few aggregateswere detected
in the ﬁrst h of the reaction (not shown). In contrast to the distribution
of aggregates obtained using 10−2 M concentrations of reactants
(Fig. 5C), the distribution produced by 10−4 M amounts of HOCl and
dopamine was skewed in favor of smaller-sized aggregates and lacked
a 1.5 μm-sized peak.
One possible barrier to the formation of aggregates in vivo is scav-
enging of HOCl and the chlorinated forms of dopamine by proteins
and other moieties. This possibility was tested by coating the reaction
vessels with albumin to scavenge chlorinating species [27]. Approxi-
mately 45 μg of albumin were attached to the surface of each reaction
vessel. This coating, however, did not inﬂuence the formation of aggre-
gates by dopamine and HOCl, at ﬁnal concentrations of 200 and 100 μM
respectively, after 4 h (c.f. Fig. 6A and B). Similar results were obtained
with reactions of 1 and 2 h durations (not shown). The albumin coating
was able to scavenge the amount of HOCl added to the reactions as
shown in Fig. 6C. In these experiments, HOCl was added to the reaction
vessel 10 min prior to the addition of dopamine which resulted in
the formation of very few aggregates. Incubation of 200 μM dopamine
on albumin-coated wells for 4 h at 22 °C also led to the generation of
aggregates (Fig. 6D). The amount of aggregates formed by dopamine
alone (Fig. 6D) was less than the amount produced by the combination
of dopamine and HOCl (Fig. 6B) and supports the notion that the
chlorination of dopamine by HOCl favors precipitation. Incubation of
dopamine on albumin-coated wells, however, produced more aggre-
gates than similar incubations on albumin-coated wells that had
scavenged HOCl (c.f. Fig. 6C and D) and suggests that the reaction of
HOCl and albumin had produced a surface that bound dopamine and
prevented the formation of aggregates.
2.6. Dopamine and HOCl at 10−8 M concentrations react to produce
aggregates
The successful observation of chlorodopamine aggregates arising
from the reaction of 10−5 M amounts of dopamine and HOCl suggested
the possibility of observing similar aggregates arising from 10−8 M
amounts of these reactants. Our initial experiments with dopamine
and HOCl - at ﬁnal concentrations of 20 and 10 nM respectively –
reacting at 22 °C produced no aggregates as detected byﬂow cytometry.
Increasing the temperature of the reaction to 37 °C, however, resulted in
the production of detectable aggregates after 3 h (Fig. 7A). A maximum
of 1,455 ± 245 (14) aggregates/s was reached by 5 h (Fig. 6A) after
which aggregates were apparently then lost from the reaction. Two
possibilities might account for this loss of aggregates: formation of
large aggregates or adherence to the reaction vesselwalls. A comparison
of the distributions presented in Fig. 7B and C support the latter mech-
anism. The furthermost right peak represents the largest aggregates
and is smaller for 24 h reaction than the 5 h reaction. Indeed all of
the peaks for the 24 h reaction are smaller than the 5 h reaction.
These observations coupled with darkening of reaction vessel walls
indicate that over time the aggregates adhere to plastic and are lost
from the measurable population. Even so, these studies indicate nM
amounts of dopamine and HOCl produce measurable quantities of
aggregates.
2.7. Aggregates of chlorinated dopamine inﬂame and kill cells
Since phagocytosis is themost likelymechanism for the activation of
glial cell by the aggregates, THP-1 cells were used to investigate the in-
gestion of these structures – and the consequences thereof – by phago-
cytic cells. As expected, differentiated THP-1 cells engulfed aggregates
within four h as shown in Fig. 8A and B. The detail from Fig. 8B illustrates
that the phagocytosed aggregates resemble the structures shown in
Fig. 5A. Prior to engulfment the aggregatesmigrate through themedium
Fig. 5. HOCl and dopamine react to form 1.5 μm diameter aggregates. Panel A depicts the ultrastructure of three aggregates produced by a 24 h reaction of HOCl and dopamine, at ﬁnal
concentrations of 10 mM and 20 mM respectively, in PBS at 22 °C. These aggregates consist of particles (A), which suggests that aggregation involves the successive addition of particles
(B). The range of detectable aggregates, asmeasured by ﬂow cytometry, is shown in panel C. These aggregateswere produced by a 4 h reaction of HOCl and dopamine, 10mMand 20mM
ﬁnal concentrations respectively, in PBS at 22 °C. The black bars in panel C represent themean of four separate experiments that varied less than 10% of themean for each value of Forward
Scatter. Supplemental Fig. 1 shows both themean± SEM for panel C. The peak position of 50 nm and 1.5mm sizemarkers is indicated in panel C (the distribution of these size markers is
shown in Supplemental Fig. 2).
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on or within the phagocytes (Fig. 8C and D). The uptake of aggregates
by THP-1 cells resulted in the death of these cells as indicated by the
incorporation of propidium iodide into the DNA of damaged cells
(Fig. 8F-H). Dead cells were evident after 4 h incubationwith the aggre-
gates (Fig. 8F). By 17 h, no viable cells remained (Fig. 8G and H) as evi-
denced by the crescents of deposited aggregates (indicated by arrows in
Fig. 8G and H); the DNA of these cells had either degraded or diffused
away. The cells in these studies were also incubated with the apoptosisindicator Annexin V Alexa Fluor®, but only exhibited staining for the
propidium iodide indicative of necrosis.
The loss of cellular viability due to aggregates was also conﬁrmed
by the measurement of lactate dehydrogenase (LDH) in the medium
bathing the cells (Fig. 8A). LDH release from THP-1 cells was appar-
ent after 24 h incubation with 6 aggregates per cell and complete
at the higher densities of 24 and 48 aggregates per cell (Fig. 9A).
These aggregates also induced a loss of LDH from differentiated SH
SY5Y cell, an in vitro model of dopaminergic cells, but only at the
Fig. 6.HOCl and dopamine at 10−5M amounts produce aggregates in the presence of a HOCl scavenger. HOCl and dopaminewere reacted in PBS at 22 °C for 4 h in either non-coated (A) or
albumin-coated (B–C) reaction vessels. In the case of panels A and B, HOCl and dopamine were added concurrently. HOCl, however, was added to an albumin-coated plate 10min prior to
the addition of dopamine in experiments shown in panel C. The distribution of aggregates arising from the auto-oxidation of dopamine on albumin plates is shown in panel D. These
distributions are shown as black bars representing the mean of four experiments that varied no more than 10% of the mean for each value of Forward Scatter. The ﬁnal concentrations
of HOCl and dopamine in these experiments were 100 and 200 μM respectively.
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(Fig. 9A). Incubation of differentiated THP-1 cells with 24 aggregates
per cells also led to a release of TNFα (Fig. 9B). This release was apparent
within two and half h of incubation and prior to any signiﬁcant loss of
viability (data not shown).
The responses of THP-1 cells and cultured microglia to aggregates
are similar with regards to phagocytosis and TNFα production [28,29].
Given this similarity, we elected to test the toxicity and inﬂammatory
nature of the aggregates by injecting these assemblages into the brain
of mice rather than testing other cell culture models. Consequently,
106 aggregates were injected into the striatum and the extent of neuro-
nal loss estimated using the methods of Petroske et al. [30] and Laloux
et al. [31]. The dopaminergic neurons present in three representative
sections of the substantia nigra were enumerated: a section rostral to
the incipient medial terminal nucleus of the accessory optic tract (MT)at−3.1 bregma, a section between incipient MT and caudal portion of
the MT at−3.4 bregma, and a section between the caudal portion of
the MT and the caudal portion of the interfasicular nucleus (IF) at
−3.7 bregma. These sections represent the rostal, intermedial, and cau-
dal portions of the substantia nigra and the values we obtained for the
control animals (those injected with ACSF) were comparable to those
reported by Laloux et al. [31]. In contrast, the injection of aggregates
resulted in a signiﬁcant loss of dopaminergic neurons (Fig. 10A–C).
This loss was accompanied by increased amounts of TNFα in the
brain three days after the injection of aggregates (Fig. 10D). The
amounts of TNFα in the whole brain were still signiﬁcantly elevated,
albeit at lower levels, 28 days post injection. These later changes
were also accompanied by increased immunohistochemical and
Western blot staining for ionized calcium binding adapter molecule
1 [32,33], a marker of activated microglia in the brain, throughout
Fig. 7.HOCl and dopamine at 10−8M concentrations produce aggregates. Aggregateswere produced by reacting HOCl and dopamine, at ﬁnal concentrations of 10 and 20 nM respectively,
in PBS at 22 °C for periods of up to 72 h. Panel A depicts the aggregates produced in either PBS or chlorodopaminemixtures as a function of reaction time and expressed as aggregates per s.
The data in panel A is a summation of distributions of the type shown in panels B and C. These values are shown as the mean and SEM of 14 experiments (A). Panels B and C depict the
distributions arising from the reaction of HOCl and dopamine forﬁve (B) and 24 (B) h; the black bars in these panels represent themean of 14 experiments that varied nomore than 10% of
the mean for each value of Forward Scatter. The inserts exhibit expanded views (Forward Scatter: 295–550) from the corresponding panels. Note: the abscissa and ordinate scales vary
between the panels and inserts.
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adapter molecule 1 staining is diffuse through brain and not shown
for this reason. These ﬁndings are consistent with the activation of
inﬂammatory response by the injected aggregates leading to the
death of neurons in brain.
3. Discussion
Our interest in the possibility that HOCl contributes to encephalitic
diseases stems from an appreciation of the destructive power of this
specie [34–37] and the lack of adequate defenses against this destruc-
tion by the brain [38–41]. Here we reported that the major product
of the in vitro reaction of HOCl and dopamine is a melanic precipitate
capable of damaging the brain. In addition, we described the use of
ﬂow cytometry to measure the aggregation responsible for the forma-
tion of these precipitates. The formation of aggregates was not inhibited
by albumin, a known scavenger of chlorination, suggesting that HOCl
preferentially reacts with dopamine. A determination of the rate at
which HOCl chlorinates the catechol moiety further supported the idea
that this oxidant reacts preferentially with dopamine in vivo.
Extracellular precipitates are typically removed by phagocytosis and the
aggregates were engulfed by phagocytic cells in vitro. This event led to
the release of TNFα from these cells and followed by necrosis. Intrastriatal
administration of 106 aggregates resulted in cerebral inﬂammation and
the loss of dopaminergic neurons from the substantia nigra.
The concept that dopamine is oxidized into harmful species has
antecedents in the studies by Bisaglia et al. (2014) and Leong et al.
(2014), and is explicable given both its amounts within the nigra and
the tendency of this catecholamine to oxidize. Nigral dopamine concen-
trations range from 10−8 to 10−1 M. Synaptic vesicles enclose 33,000molecules of dopamine which equates to a local concentration of
0.3 M [42], vesicular release results in extrasynaptic accumulations of
up to 50nMdopamine [18,19], and the cytosol of dopaminergic neurons
contains 50 μM amounts of this neurotransmitter [20,21]. Dopamine
readily oxidizes to a variety of reactive species that undergo polymeri-
zation and aggregation to form melanins [6,7]. Here we demonstrated
that the oxidation of dopamine by HOCl - a reactive oxygen species
known to be produced in neurodegenerative diseases [1,5,43,44] -
produced melanic aggregates capable of damaging the brain. This dam-
age is likely to be due to the phagocytosis of the particles by microglia
near the injection sites. Incubation of differentiated THP-1 cells with
as little as six aggregates per cell was sufﬁcient to damage these cells
(Fig. 9A). THP-1 cells phagocytose up to 40 latex particles per cell with
no ill effects [45]. The toxicity of the aggregates is probably due to the
incorporated chloride (Table 1). Treatment of aggregateswith hydrogen
sulﬁde removed some of the chloride atoms and generated particulate
material that neither killed THP-1 cells nor caused these cells to secrete
TNFα (Jeitner and Kalogiannis: unpublished ﬁndings).
HOCl is formed in the AD and PD brain as evidenced by the produc-
tion of HOCl-modiﬁed proteins [2,3,5] and 3-chlorotyrosine [1]. The
pathological production of HOCl in the brain is also indicated by the
availability of myeloperoxidase and its substrate H2O2 (Reaction 1).
Myeloperoxidase is present in the glial cells affected by AD and PD [1,
43,44,46–48] as well as neurons in the AD brain [1]. Moreover, Choi
et al. [5] demonstrated this enzyme is catalytically active in nigral ex-
tracts from parkinsonian mice. Hydrogen peroxide is released from
the nigral neurons in a pulsatile manner with amplitude of 4.8 μM and
a frequency 8.2 min−1 [19]. The levels of this peroxide are expected to
be higher in PD since the majority of disease-causing gene mutations
and toxins prompt mitochondrial complex I to reduce oxygen to
Fig. 8. Phagocytic cells engulf chlorodopamine aggregates and then die. Shown are electron micrographs of differentiated THP- 1 cells incubated in the absence (A) and presence (B) of
aggregates. In each case, the large organelle dominating the left side of the cells is the nucleus, while the phagocytic vacuole dominates the right side. The dark globular structures present
within the phagocytic vacuole are engulfed aggregates (B). These aggregates are also shown at 2.5× greater magniﬁcation in the detail taken from panel B and resemble the assemblages
shown in Fig. 2A. THP-1 cells were incubated with 48 aggregates per cells for varying times (e.g. 4 h in B). The association of the particles with THP-1 cells after 2.5 h is shown in panels C
and D at 100 and 400× magniﬁcations respectively. Panels E and F represent the while light and red ﬂuorescence (propidium iodide) images of the same visual ﬁeld after 4 h incubation
with aggregates. The arrows indicate the same cell in each ﬁeld (E and F). Similarly, THP-1 cells stained with propidium iodide after 17 h incubation with aggregates is shown in panels G
and H at 100 and 200× magniﬁcations respectively. The arrows indicate the same cell in both ﬁelds as a deposit of engulfed aggregates but lacking a stained nucleus.
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tion, the addition of rotenone to nigral neurons increased the amount of
H2O2 released by these cells above the aforementioned basal levels [19].Myeloperoxidase is usually constrainedwithin cells or to the glycocalyx
when released [50]. Therefore, the amount of Cl− oxidized to HOCl is
limited by the diffusion of H2O2 to the enzyme. In practice this is not a
Fig. 9.Chlorodopamine aggregates cause cells to release of LDHand TNFα. Differentiated THP-1 cellswere incubatedwith 0, 3, 6, 12, 24 or 48 aggregates per cellswhereas differentiated SH
SY5Y cells were incubated with 0, 6.25, 12.5, 25, 50 or 100 aggregates per cells for 24 h. LDH release into the cell media after 24 h incubation was expressed as a percentage of the LDH
content present (A). The basal amounts of LDH released into the media of THP-1 and SH SY5Y cells were 4.78 ± 2.68% and 6.02 ± 0.49% of the total cellular content of LDH respectively.
Panel B shows the cell media concentrations of TNFα after a 2.5 h incubation of THP-1 cells with and without 24 aggregates per cells. Shown are the mean ± SEM for three independent
experiments performed using THP-1 cells and ﬁve experiments using SH SY5Y cells.
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water. Even so, conversions 1 to 10% of the 4.8 μMH2O2 produced by do-
paminergic neurons [19] would still generate between 48 to 480 nM
amounts of HOCl, which aswe have demonstrated is sufﬁcient to chlo-
rinate dopamine (Figs. 1 and 2). The presence of 3-chlorotyrosine
and HOCl-modiﬁed proteins indicates that at least a portion of the
H2O2 produced in the parkinsonian and AD brain is used to oxidize
Cl− to HOCl [1,5].
HOCl and dopamine are likely to react in vivo based on our determi-
nation of the second-order rate constant for this reaction of 2.5 ×
104 M−1 s−1. This constant lies within the range of the values derived
for the oxidation of amines by HOCl, namely 103–105 M−1 s−1 [36,
51]. Since amines are oxidized by HOCl in vivo [36], dopamine must
also be chlorinated under same conditions. The congruence of the con-
stants for the reactions of amines and dopamine with HOCl indicates
that some amines will compete with dopamine for reaction with HOCl,
which we conﬁrmed with ethanolamine and NH4Cl (not shown).
While this competition may limit the reaction between dopamine and
HOCl, it should be noted that chloramines are also potent chlorinating
agents [52,53]. The rate at which dopamine is chlorinated by HOCl
is also at least 300 times faster than the rate at which tyrosyl resides
are converted to 3-chlorotyrosine by HOCl: 71 M−1 s−1 [54]. Since
3-chlorotyrosine levels [2,3] are elevated in the brains of AD patients
and parkinsonian mice [1,5] HOCl must react with catecholamines if
formed in the vicinity of these neurotransmitters.
1H-NMR spectrometry revealed that themajor product of the reaction
of HOCl and dopamine was 5-chloro-4-(2-aminoethyl)benzene-1,2-diol
followed by the production of N,5-dichloro-4-(2-aminoethyl)benzene-
1,2-diol, N-chloro-4-(2-aminoethyl)benzene-1,2-diol, and trace amounts
of N-dichloro-4-(2-aminoethyl)benzene-1,2-diol (compounds I-IV,
respectively, in Fig. 11). These products were observedwhen the reaction
was performed in acidiﬁed methanol. Even so, the formation of
compound I in aqueous solutions was indicated by the loss of dopamine
ﬂuorescence following the addition of HOCl. The catechol ring of
dopamine is primarily responsible for the ﬂuorescence of this molecule
and the loss of this ﬂuorescence due to HOCl is probably due to ringchlorination. This reaction may result from interactions with HOCl or
one of the chloramines formed by the reaction between HOCl and the
amine group of dopamine: compounds II-IV (Fig. 11). Compound I
could also arise from chlorination of the ring at the 5 position by the
neighboring chloramine in compound III. This aryl carbon can react
with the alkyl amine as indicated by the facile formation of 5,6-
hydroindole under oxidizing conditions [6]. Interestingly, 5,6-
hydroindole was not detected following the reaction of dopamine and
HOCl in acidiﬁed methanol (using 1H-NMR spectrometry) or aqueous
solutions (using thin-layer chromatography). 5,6-hydroindole was of
interest because it participates in the production of melanins [6] and
the spectral properties of this dye [55] are comparable to those reported
in Fig. 1.
The products of the reaction of HOCl and dopamine rapidly polymer-
ized to form the spherical structures with diameters of approximately
50 nm. These dimensions are comparable to those reported for the
smallest particles contained in human neuromelanin [56,57] and
suggest that the polymerization of oxidized dopamine is limited.
This is explicable given the wealth of compounds resulting from the
chlorination or oxidation of dopamine as described here and elsewhere
[6]. The polymers arising from these products are expected to contain
signiﬁcant amounts of amorphous regions and therefore unlikely to
grow beyond a certain size [58]. The presence of chloride in the aggre-
gates and the rapid polymerization of acidiﬁed solution of chlorinated
dopamine brought to neutrality, support the notion that the chlorinated
forms of dopamine polymerized to form nm-sized particles.
These particles then self-associated to form a wide variety of
differently-sized aggregates as demonstrated by ﬂow cytometry and
electron microscopy.
To our knowledge, this report is the ﬁrst to describe the use of ﬂow
cytometry to study the in vitro formation of aggregates. The current
methods available for such studies are limited to studying the assembly
of a few aggregates (e.g., dynamic light scattering and chromatography)
or of aggregation in bulk (e.g., turbidity measurements). Flow
cytometry performs light scattering measurements on an
aggregate-by-aggregate basis to yield a frequency distribution of
946 T.M. Jeitner et al. / Biochimica et Biophysica Acta 1852 (2015) 937–950aggregates ranging from nm to μm dimensions. Moreover, the light
scattering properties of hundreds of thousand aggregates can be collected
within minutes. Here we demonstrated that ﬂow cytometry can detect
the aggregates arising from as low as 10−8 M amounts of reactants, and
that aggregation proceeds by the successive addition of particles to
yield a dominant population of aggregates with an average diameter
of 1.5 μm.
The above arguments and the data presented herein vindicate the
notion that HOCl – when formed in the vicinity of dopamine – will
react with this catecholamine to form melanic species that participate
in the development of PD. The ease with which aggregates form
under the in vitro conditions cited here is a good indicator that these
assemblages form in vivo and likely to be plentiful given the relative
abundance of dopamine, H2O2, Cl− and myeloperoxidase in the
diseased substantia nigra. Myeloperoxidase is expressed in AD [1,43]
as well as PD. This enzyme is also delivered to the brain by neutrophils
andmacrophage following strokes and other injuries [46,59]. The possi-
bility that HOCl is produced in a variety of neurodegenerative disorders
and produces species that are both inﬂammatory and toxic suggests
that chlorinative stress contributes signiﬁcantly to these diseases.
Aggregates formed from the reaction of HOCl and catecholamines may
be both important remnants and propagators of this stress, and as
such, deserve further consideration.
4. Methods
4.1. Materials
The Diff-Quik staining kit was obtained from Siemens Healthcare
Diagnostics Inc. (Newark, DE). Primary antibodies were bought from
Abcam (Cambridge, MA) whereas the secondary antibodies were sup-
plied in the kits purchased from ImmunoCruz (Santa Cruz, CA) for im-
munohistochemical staining and the Amersham ECL Western Blotting
Analysis System (GE Healthcare). Ladd industries (Burlington, VT) sup-
plied the Epon epoxy resin. Annexin V Alexa Fluor® 488 and propidium
iodide were bought from Invitrogen (Carlsbad, CA). The ELISA kit for
Tumor Necrosis Factor-α (TNFα was obtained from (BD Biosciences,
San Jose, CA). Pre-cast 15% gels were bought from Bio-Rad (Hercules,
CA) and Immbilon PDVFmembranes fromMillipore (Millipore, Billerica,
MA). The Halt protease inhibitor cocktail mix was obtained from
Thermo Scientiﬁc (Pittsburgh, PA). PlasticsOne (Roanoke, VA) supplied
the cannulae for microinjection. Duke Standards (0.5, 1.0 and 1.5 μm)
were obtained from Thermo Scientiﬁc. All other reagents were
purchased from Sigma-Aldrich (St. Louis, MO).
4.2. Animals
Adult male C57/Bl6 mice aged 8–10 weeks old (20–26 g) were
housed individually. Mice were acclimated to the institution's Animal
Care Facility for 1week prior to surgery and allowed oneweek to recover
post-surgery. All protocols used in this study were reviewed and
approved by the Institutional Animal Care and Use Committee of
Winthrop University Hospital and were compliant with NIH guidelines
for ethical treatment of animals.
4.3. Preparation of aggregates from the reaction of HOCl and dopamine
Aggregates were prepared in 10 ml lots with dopamine and HOCl in
PBS at ﬁnal concentrations of 20 and 10mM, respectively. The reactants
were allowed to react for 24 h at 22 °C (room temperature) andwith 30
rotations per min of the reaction vessels. The HOCl concentration was
determined by titration with 2-nitro-5-thiobenzoate as described by
Jeitner et al. [60]. Particulate material forms in most standing solutions.
Consequently the PBS used for these studieswasﬁltered through 0.2 μm
pores prior to its use. Precipitates resulting from the aforementioned re-
action were collected with centrifugation at 600×g for 15 min at 4 °C.Nine mL of the supernatant resulting from this centrifugation was
discarded and the remainder used to transfer the aggregates to 1.5 mL
centrifuge tubes for centrifugation at 10,000×g for 15 min at 4 °C. The
resulting pellet was resuspended in 1.5 mL H2O and centrifuged again.
This process was repeated for a total of three centrifugations at
10,000×g. The ﬁnal pellet was resuspended in artiﬁcial cerebrospinal
ﬂuid artiﬁcial (ACSF: 124 mM NaCl, 5 mM KCl, 1.2 mM NaH2PO4,
2.7 mM CaCl2, 1.2 mMMgSO4, 26 mM NaHCO3 and 10 mM D-Glucose),
tissue culture medium, or H2O depending on ﬁnal use of the aggregates.
In the case of the elemental analysis and embedding studies, the aggre-
gates were dried by rotary evaporation.
4.4. Elemental analysis
The elemental analyses were performed by Micro-Analysis, Inc.
Wilmington, DE 19808.
4.5. Flow cytometric determination of aggregation
Flow cytometry was performed using a BD FACSArray with the
ﬂow rate adjusted to 0.5 mL/min and the power of the laser adjusted
to the lowest values that distributed the aggregates as a diagonal in a
dot plot of Forward Scatter and Side Scatter. A total of 105 light scat-
tering events were analyzed for each sample. The maximum time for
sample collection, however, was limited to 200 s to avoid exceeding
the sample volume per well. This limit meant that some samples
contained less than 105 events. Thus, the data was normalized by di-
viding the number of events by the collection time for each sample.
The aggregation studies performed at 22 °C utilized 35mmdiameter
vessels, typically in six well plates. Each well contained 2 mL of ﬁltered
PBS and various combinations of dopamine and HOCl. The reactions
were performed at 30 rotations per min and started with the addition
of HOCl. Samples of 0.2 mL were removed later for the analysis of 105
events as described above. In some experiments the wells were coated
with bovine serum albumin (Cohn Fraction V), which was applied as a
5 mg/mL 100 mM carbonate (pH 9.6) solution and incubated overnight
at 4 °C. The coated wells were washed three times with ﬁltered PBS
immediately prior to the start of the experiments.
The aggregation studies performed at 37 °C utilized 15 mL polypro-
pylene tube. A total of 10 mL ﬁltered PBS containing 20 nM dopamine
was rotated at 30 rotations per min following the addition of HOCl to
a ﬁnal concentration of 10 nM. Samples of 0.2 mL were removed later
for the analysis of 105 events as described above.
4.6. Spectrophotometry
UV-visible specta for dopamine were collected using a Shimadzu
UV – 1601PC spectrometer and UVProbe software (Shimadzu Scientiﬁc
Instruments Inc., Columbia,MD). All reactionswere performed in quartz
cuvettes and at 22 °C.
The loss of dopamine ﬂuorescence due to chlorination by HOCl was
monitored at an emission wavelength of 315 nm due to excitation at
270 nm (slit width for both wavelengths was 5 nm). These studies
were carried out using a Photomultiplier Detection System 710 and
the FelixGX software (Photon Technology International, Birmingham,
NJ). The reactions were performed in quartz cuvettes and a volume of
2.5 mL at 22 °C.
4.7. 1D 1H-NMR
1D 1H-NMR spectra were obtained on a Varian INOVA 500 MHz
spectrometer using the following acquisition parameters: 90° pulse,
32 transients of 32 K data points were collected with a sweep width of
6,000 Hz (12 ppm), 8 sec relaxation delay during which presaturation
of the water signal was applied for 2 sec. The total acquisition time
Fig. 10. Intrastriatal administration of chlorodopamine aggregates results in inﬂammation and neuronal loss. Representativemicrographs of tyrosinehydroxylase staining in the substantia
nigra 4 weeks after the intrastriatal injections of either ACSF (A) or 106 chlorodopamine particles (B). SN: substantia nigra, cp: cerebral peduncle, MN: mamillary nucleus Bar = 250 μm.
Magniﬁcation at 400x, 40 μm thick sections. The neuronal loss due to the injection of particles was quantiﬁed and presented in panel C as the mean and SEM for three mice treated with
ACSF and ﬁvemicewith 106 particles. The TNFα production induced three and 28 days after the administration of particles is given the panel D as themean and SEM of thee experiments.
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Livermore, CA).
4.8. Cell culture
The humanmonocytic cells THP-1weremaintained in amedium con-
taining RPMI medium, bovine calf serum and 10,000 U/mL Penicillin/
Streptomycin (v:v:v, 89:10:1), at between 2.5 × 105 and 106 cells
per mL. For each experiment, the cells were diluted at a density of
2.5 × 105 per mL and treated with 100 nM phorbol 12-myristate 13-
acetate to induce differentiation to phagocytic phenotype. Immediately
following the addition of the phorbol ester, the cells were seeded in a
volume of 0.5 mL per well of 24 multiwell plates to yield 6.25 × 104
cells per cm2. Forty eight hours later, the mediumwas removed and re-
placed with either 0.3 mL fresh medium or medium containing graded
amounts of aggregates. After a further 24 h of incubation, 0.25 mL ofthe medium bathing the cells was removed and assessed for lactate
dehydrogenase activity as a measure of cell viability. Care was taken
to ensure to not disturb the settled aggregates while removing the
medium. In one group of cells treated with medium alone, the medium
was removed and replaced with 0.3 mL RIPA buffer to lyse the cells to
quantify the intracellular lactate dehydrogenase activity. The activity
present in the medium was expressed as a function of the total cellular
activity.
Neuroblastoma-derived SH SY5Y cells were maintained in medi-
um composed of F12/MEM (1:1), bovine calf serum and Penicillin/
Streptomycin (89:10:1). In preparation for the experiments, the cells
were diluted a density of 6.0 × 104 per mL and seeded in a volume of
0.5 mL per well of 24 multiwell plates to yield 3 × 104 cells per cm2.
The next day the medium was replaced with medium containing
10 μM retinoic acid to induce cellular differentiation. This treatment
was repeated four more times every other day for a total of ﬁve
Fig. 11. Compounds formed by the reaction of HOCl and dopamine. The products shown were based on the 1H-NMR studies (see text and Fig. 3). RCl refers to either HOCl or the
chloramines indicated in the ﬁgure: compounds II-IV.
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and 48 h of the last retinoic acid treatment. Retinoic acid was prepared
as a 10 mM solution in ethanol and stored at−20 °C.
4.9. Enzymatic assay of cell viability
The release of lactate dehydrogenase (LDH) into the medium condi-
tioned by cells was used to measure the toxicity of aggregates to THP-1
and SH SY5Y cells. These experiments began with replacement of the
culture medium with 0.3 mL fresh medium containing either 0, 1.25,
2.5, 5, 10 or 20 × 103 aggregates per μL per well. Twenty four h later
0.25 mL of the medium was removed and combined with 2.5 μL 10%
Triton X-100. Two hundred μL of this solution was assayed for LDH
activity as described by Beutler [61]. THP-1 and SH SY5Y cells were
seeded at 6.25 × 104 and 3 × 104 cells per cm2 and differentiated within
24 h. Since the cell density did not alter signiﬁcantly during the course
of the experiments the seeding densities were used to calculate the
aggregates added per cell values.
4.10. Electron microscopy
The electron micrographs of aggregates were prepared using mix-
tures of dopamine and HOCl (at ﬁnal concentrations of 20 and 10 mM,
respectively) that reacted for at least 24 h at 22 °C and 30 rotations
per min. A drop of this mixture was added onto an aluminum block
and left undisturbed to allow the aggregates within the drop to settle
on to the block surface, after which the excess ﬂuid was wicked off
with absorbent ﬁlter paper. Another drop was then added and proce-
dure repeated for a total of four drops. The resulting grids were then
post-stained with uranyl acetate and lead citrate and visualized on a
Zeiss EM 10 transmission electron microscope retro-ﬁtted with an SIA
L3C digital camera (SIA, Duluth, GA).
The cells used in these studies were ﬁxed in 4% glutaraldehyde buff-
ered in 0.1 M sodium phosphate buffer, pH 7.5, washed with the samebuffer, post-ﬁxed in buffered 1% osmium tetroxide, en-bloc stained
with a saturated solution of uranyl acetate in 40% ethanol, dehydrated
in a graded series of ethanol, inﬁltrated with Epon epoxy resin, and
embedded in the culture dish. Upon curing, the resin containing the
samples was removed from the plastic culture dish, a small piece
removed with a jeweler's hacksaw and glued to an aluminum block
for en-face thin sectioning. The resulting grids were then post-stained
and visualized as described earlier.
4.11. Stereotaxic microinjections
Mice were surgically implanted with guide cannula (Plastics1) fol-
lowing a modiﬁed protocol adapted from Gao et al. [62]. Brieﬂy, mice
were anesthetized with ketamine (100 mg/kg)/xylazine (3.5 mg/kg)
i.p. and placed in a Kopf model 962 stereotaxic frame (Tujunga, CA,
USA) to enable the placement of 26 gauge stainless steel guide cannulae
(Plastics 1, Roanoke, VA) 0.26mmanterior to bregma, 1.5 mm lateral to
the midline and 2.0 mm ventral to the surface of the skull [63]. One
week later, 32 gauge internal cannulae were placed into the guide
cannulae to enable the injection of either ACSF or 106 aggregates in
ACSF. The internal cannulae extended 0.5 mm past the guide to access
the striatum. A total of 2 μL was delivered over a 6 min period via a
positive displacement microinjector (Tritech Research, Los Angeles)
and a 10 μl Hamilton syringe series 7000 (Hamilton, Reno NV). Two
minutes later the internal cannulae were removed to prevent backﬂow
and were replaced with dummy cannulae.
4.12. Tissue preparation for histology and Western blotting
Micewere killed by an overdose of euthasol (150mg/kg) i.p. and the
brains excised and bisected. The hemisphere ipsilateral to the cannula
was submerged in 4% paraformaldehyde in phosphate buffered saline
overnight, followed by immersion in 30% sucrose prepared in phos-
phate buffered saline. This tissue was then sectioned as 40 μm sections
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brain hemisphere was homogenized in ice cold lysis buffer (25 mM
Tris–HCl, 0.25 M sucrose, 2 mM EDTA, 10 mM EGTA, 1% Triton X-100,
and 10 μL/mL Halt protease inhibitor cocktail mix (Thermo Scientiﬁc,
Pittsburgh, PA)) at 100 mg tissue/mL, centrifuged at 12, 000×g for
20 min at 4 °C, and resulting supernatants analyzed for protein and
cytokine content. Protein concentrations were determined with the
Bradford assay [64].
4.13. Tyrosine hydroxylase immunocytochemistry
Free ﬂoating sectionswere pretreatedwith peroxidase block and in-
cubated for 1 h in goat serum using the ImmunoCruz staining system.
Sections were then incubated overnight at 4 °C with rabbit anti-TH
(1:1000). The following day sections were treated with the biotinylated
secondary, the HRP-streptavidin complex and visualized with diamino-
benzidine. Cells were counted as described previously [30,65] using
stereotaxic coordinates deﬁned by Franklin and Paxinos [63]. Stained
sections were visualized by light microscopy (Nikon Eclipse TE300,
Nikon USA, Melville, NY). Images were taken with the Nikon DS-Ri1
and processed with the NIS-Elements 3.2 (Nikon). The substantia
nigra boundaries were established as previously described [30]. Micro-
photographs for TH neurons were taken at a 40× magniﬁcation.
Neurons were counted under a light microscope at a magniﬁcation of
×400. A neuron was counted if nucleus was visible and one or more
clearly deﬁned processes tapered gradually from the cell body.
This number was considered to be representative of the number of
dopaminergic nigral cells in each animal. The counts were taken of
three individual sections from each mouse.
4.14. TNFα ELISA
TNFα levels in the brain tissue and tissue culture medium were
measured with the mouse TNFα ELISA kit.
4.15. Statistics
The differences between experimental groups were assessed
by ANOVA and any signiﬁcant differences are indicated by * and ** for
p values b 0.05 and 0.01, respectively. Graphical ﬁttingswere performed
using the SigmaPlot program (Systat Software).
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